Phase
Alumni
Akuru Pharma
Akuru Pharma AB is a biomedical company focusing on exploiting the abnormal expression of transporter proteins in kidney cancer for developing novel diagnostic and treatment modalities.
CEO short bio: Jennifer Hansson, PhD i Tumor Biology from Lund University, expertise in kidney regeneration and kidney cancer.
Jennifer Hansson, PhD i Tumor Biology from Lund University, expertise in kidney regeneration and kidney cancer.
Excellence in solid material analysis
Unique stem cell therapeutics
Amplify the efficacy of pharmaceutical treatments
Simplify medicine information through digital services
A "check-in buddy" for the elderly
Excellence in inhaler performance
Behavioral coaching app
Antibiotic-free treatment for vaginal bacterial infections
Digital tool for meeting an allergy doctor
Cutting-Edge Histological Solutions for Pharma Industry
Digital communication tool for titrating medicine
Mobile systems for movement analysis
Innovative solutions for better health care
GPS tracker system for elderly
Drug delivery platform
Digital assistive device for post-surgical rehabilitation
Healthtech for children with eating challenges
Digital health management tool
Short chain fatty acids can be delivered to the colon
Therapeutics after stroke
Starch pickering emulsion technology
Effective treatments for brain tumors
Measuring thyroid hormone levels
Gene editing analysis solution
Cost-effective & rapid COVID-19 diagnostic test
eHealth clinic for obesity treatment
